Dr. Sagar Sardesai, MD
Claim this profileOhio State University Comprehensive Cancer Center
Expert in Breast Cancer
Studies Lobular Carcinoma in Situ
14 reported clinical trials
25 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage III
HER2 positive
Stage II
2Lobular Carcinoma In Situ
BRCA1 positive
BRCA2 positive
Stage II
Affiliated Hospitals
Clinical Trials Sagar Sardesai, MD is currently running
Acolbifene vs. Tamoxifen
for Breast Cancer Prevention
This trial is testing two pills, acolbifene and low dose tamoxifen, to prevent breast cancer in premenopausal women at high risk. These women are chosen because they have a much higher chance of developing breast cancer. The drugs work by blocking estrogen, which can help stop the growth of cancer cells. Acolbifene is being assessed for breast cancer prevention, while tamoxifen has been widely studied and used for reducing breast cancer risk.
Recruiting1 award Phase 216 criteria
Inspiratory Muscle Training
for Breast Cancer Survivors with Obesity
The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.
Recruiting0 awards N/A4 criteria
More about Sagar Sardesai, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sagar Sardesai, MD has experience with
- Fulvestrant
- Tamoxifen
- Paclitaxel
- EMBr Wave
- Acolbifene Hydrochloride
- Omega-3 Fatty Acids
Breakdown of trials Sagar Sardesai, MD has run
Breast Cancer
Lobular Carcinoma in Situ
Ductal Carcinoma In Situ
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sagar Sardesai, MD specialize in?
Sagar Sardesai, MD focuses on Breast Cancer and Lobular Carcinoma in Situ. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Sagar Sardesai, MD currently recruiting for clinical trials?
Yes, Sagar Sardesai, MD is currently recruiting for 5 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Sagar Sardesai, MD has studied deeply?
Yes, Sagar Sardesai, MD has studied treatments such as Fulvestrant, Tamoxifen, Paclitaxel.
What is the best way to schedule an appointment with Sagar Sardesai, MD?
Apply for one of the trials that Sagar Sardesai, MD is conducting.
What is the office address of Sagar Sardesai, MD?
The office of Sagar Sardesai, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.